Steven Bramwit, MD
Otolaryngology · Greenwich, CTNPI 1730183146
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Optinose US, Inc. at 31.7% of the total.
Across 138 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$936
- GSK$560
- Acclarent, Inc$275
- Intersect ENT, Inc.$246
- Arbor Pharmaceuticals, Inc.$192
- Aerin Medical Inc.$167
- plus $577 from 14 others
What the payments were for
- Food & beverage$2,954100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 55 | $936 |
| GSK | 33 | $560 |
| Acclarent, Inc | 4 | $275 |
| Intersect ENT, Inc. | 10 | $246 |
| Arbor Pharmaceuticals, Inc. | 10 | $192 |
| Aerin Medical Inc. | 3 | $167 |
| Stryker | 4 | $161 |
| Sanofi | 5 | $98 |
| Novartis | 2 | $47 |
| Integra Lifesciences Corporation | 1 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Boston Scientific | 1 | $35 |
| Neurent Medical Limited | 1 | $29 |
| Medtronic | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Freudenberg Medical, LLC | 1 | $20 |
| Smith+Nephew | 1 | $17 |
| Photonicare Inc | 1 | $17 |
| Alk-abello, Inc | 1 | $15 |
| Glenmark Therapeutics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,954 in reported general payments places this provider in the 65th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 11 | $41,385 |
| Olopatadine Hcl | 118 | $10,912 |
| Hydrocortisone-Acetic AcidHydrocortisone/Acetic Acid | 66 | $7,053 |
| Azelastine Hcl | 132 | $5,614 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 103 | $4,830 |
| Cefdinir | 140 | $2,946 |
| Ipratropium Bromide | 46 | $1,341 |
| Fluticasone Propionate | 40 | $447 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $438 |
| Fluocinolone Acetonide Oil | 14 | $417 |
| Methylprednisolone | 21 | $209 |
| Ofloxacin | 11 | $182 |
| Clarithromycin | 11 | $178 |
| Azithromycin | 28 | $144 |
| Meclizine Hcl | 14 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala | $560 | $41,38511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 119 otolaryngology providers in Connecticut.
Other otolaryngology in Greenwich
- Richard BrauerGreenwich$4K
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard StupakWestport$48K
- Belachew TessemaFarmington$45K
- Seth BrownFarmington$39K
- Howard BoeyNew Haven$19K
- Mahesh BhayaWaterbury$11K
- Neil SchiffWaterbury$10K
- Benjamin WycherlyFarmington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.